GB1354263A - Therapeutic composition - Google Patents

Therapeutic composition

Info

Publication number
GB1354263A
GB1354263A GB2593172A GB2593172A GB1354263A GB 1354263 A GB1354263 A GB 1354263A GB 2593172 A GB2593172 A GB 2593172A GB 2593172 A GB2593172 A GB 2593172A GB 1354263 A GB1354263 A GB 1354263A
Authority
GB
United Kingdom
Prior art keywords
therapeutic composition
june
therapeutic
composition
theranol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2593172A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
THERANOL LAB
Original Assignee
THERANOL LAB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by THERANOL LAB filed Critical THERANOL LAB
Publication of GB1354263A publication Critical patent/GB1354263A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis

Abstract

1354263 Therapeutic compositions LABORATOIRE THERANOL 2 June 1972 [3 June 1971] 25931/72 Heading A5B A therapeutic composition comprises L-thyroxine (as such or as a salt), 3, 3', 5-triiodothyroacetic acid, and a diffusion factor such as hyaluronidase, dissolved in a pharmaceutically acceptable vehicle which is tooth a solvent for the constituents of the composition and miscible with water, and which contains a wetting agent.
GB2593172A 1971-06-03 1972-06-02 Therapeutic composition Expired GB1354263A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7120183A FR2139748B1 (en) 1971-06-03 1971-06-03

Publications (1)

Publication Number Publication Date
GB1354263A true GB1354263A (en) 1974-06-05

Family

ID=9078067

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2593172A Expired GB1354263A (en) 1971-06-03 1972-06-02 Therapeutic composition

Country Status (8)

Country Link
JP (1) JPS5212779B1 (en)
BE (1) BE784267A (en)
CA (1) CA982477A (en)
CH (1) CH572744A5 (en)
DE (1) DE2226927A1 (en)
ES (1) ES403317A1 (en)
FR (1) FR2139748B1 (en)
GB (1) GB1354263A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996040048A2 (en) * 1995-06-07 1996-12-19 Karo Bio Ab Novel uses for thyroid hormones or thyroid hormone-like compounds
US6380255B1 (en) 1995-06-07 2002-04-30 Karo Bio Ab Treatment for dermal skin atrophy using thyroid hormone compounds or thyroid hormone-like compounds
GB2457710A (en) * 2008-02-25 2009-08-26 Andrew Nicolaou Thyroxine and its use in weight loss and obesity treatment

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH622703A5 (en) * 1976-06-10 1981-04-30 Berema Sa Therapeutic compositions for treating deposits of excess fat and infiltrates causing cellulite
US4525359A (en) * 1982-12-10 1985-06-25 Greenway Frank L Iii Treatment for selective weight control

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996040048A2 (en) * 1995-06-07 1996-12-19 Karo Bio Ab Novel uses for thyroid hormones or thyroid hormone-like compounds
WO1996040048A3 (en) * 1995-06-07 1997-11-13 Karobio Ab Novel uses for thyroid hormones or thyroid hormone-like compounds
US6380255B1 (en) 1995-06-07 2002-04-30 Karo Bio Ab Treatment for dermal skin atrophy using thyroid hormone compounds or thyroid hormone-like compounds
EP1398024A3 (en) * 1995-06-07 2004-12-15 Karo Bio Ab uses for thyroid hormones compounds
GB2457710A (en) * 2008-02-25 2009-08-26 Andrew Nicolaou Thyroxine and its use in weight loss and obesity treatment

Also Published As

Publication number Publication date
DE2226927A1 (en) 1973-01-18
CA982477A (en) 1976-01-27
JPS5212779B1 (en) 1977-04-09
FR2139748A1 (en) 1973-01-12
ES403317A1 (en) 1976-04-01
CH572744A5 (en) 1976-02-27
FR2139748B1 (en) 1974-08-30
BE784267A (en) 1972-12-01

Similar Documents

Publication Publication Date Title
ES405553A1 (en) Amino derivatives of pyrazolopyridine carboxylic acids and esters
IE34676B1 (en) Benzimidazo (2,1-b) quinazolin derivatives as immuno suppressants
IE42340L (en) 11,12-secoprostaglandins
ES419560A1 (en) N-1-alkoxycarbonyl-ethyl-n-haloacetyl-2,6-dialkylanilines and their microbicidal use
GB1319103A (en) Alpha,beta-poly aspartic acid-hydroxy-alkylamides
GB1263000A (en) 4,4',4''-trihydroxytriphenylmethylmethane and process for preparing it
GB1354263A (en) Therapeutic composition
AU449293B2 (en) New adenosine-5'carboxylic acid derivatives andthe preparation thereof
GB1403900A (en) Pharmaceutical composition
ES451880A1 (en) Toothpaste compostion
IE34609B1 (en) Antineoplastic therapeutic compositions
GB1463975A (en) Skin compositions
GB1388856A (en) Fibrinolytic activators comprising derivatives of phenyl benzoate
GB1353834A (en) Benzenesulphonamides
GB1254057A (en) Improvements in or relating to therapeutical composition containing vincamine
GB1465771A (en) Pharmaceutical composition and use thereofd
GB1287433A (en) Pharmaceutical compositions
GB1437788A (en) Therapeutic compositions
FR2081580A1 (en) Pharmacol-active 2,4,6-trimethoxybenzoates
GB909365A (en) Orally ingestible solid penicillin compositions
GB1109964A (en) Complex of theophylline and soluble saccharin, process for its preparation and therapeutic composition comprising same
GB1290468A (en)
GB1330993A (en) Mixture of l-dopa and 2-imino-5-phenyl-4-oxazolidinone used to treat parkinsons disease
GB1417817A (en) Substituted acetic acid cyclohexyl esters the preparation thereof and pharmaceutical compositions containing them
CA835959A (en) PREPARATION OF ESTERS OF .alpha.,.alpha.'-DIMETHYLMUCONIC ACID

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee